BENITEC BIOPHARMA LTD's ticker is BNTC and the CUSIP is 082053307. A total of 6 filers reported holding BENITEC BIOPHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $10,000 | 0.0% | 13,700 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -63.0% | 13,700 | 0.0% | 0.00% | – |
| Q1 2019 | $27,000 | +28.6% | 13,700 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -34.4% | 13,700 | 0.0% | 0.00% | – |
| Q3 2018 | $32,000 | -54.9% | 13,700 | -50.0% | 0.00% | – |
| Q2 2018 | $71,000 | +61.4% | 27,400 | +100.0% | 0.00% | – |
| Q1 2018 | $44,000 | +7.3% | 13,700 | 0.0% | 0.00% | – |
| Q4 2017 | $41,000 | – | 13,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,365,615 | $971,000 | 0.52% |
| Virtu Financial LLC | 11,263 | $8,000 | 0.00% |
| UBS Group AG | 6,009 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 79,200 | $56,000 | 0.00% |
| Renaissance Technologies | 13,700 | $10,000 | 0.00% |